Multiple factors potentially contribute to the progression of cancer in obesity and type 2 diabetes mellitus, including hyperinsulinemia and insulin-like growth factor I, hyperglycemia, dyslipidemia, adipokines and cytokines and the gut microbiome. This evidence concerns the gene IGF1 and hyperinsulinism.